Aclaris Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(2.9%)
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-董事 Humphries William D.
Aclaris Therapeutics | 4:持股变动声明-董事 MILANO VINCENT
Aclaris Therapeutics | 4:持股变动声明-董事 Molineaux Christopher P.
Aclaris Therapeutics | 4:持股变动声明-董事 GOWEN MAXINE
Aclaris Therapeutics | 4:持股变动声明-董事 Mehra Anand
Aclaris Therapeutics | 4:持股变动声明-董事 SCHIFF ANDREW N
Aclaris Therapeutics | 4:持股变动声明-董事 Humphries William D.
Aclaris Therapeutics | 4:持股变动声明-董事 Molineaux Christopher P.
Aclaris Therapeutics | 4:持股变动声明-董事 Powell Andrew Kenneth William
Aclaris Therapeutics | 4:持股变动声明-董事 Reasons Bryan M.
Aclaris Therapeutics | 4:持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 4:持股变动声明-董事 GOWEN MAXINE
Aclaris Therapeutics | 4:持股变动声明-董事 Mehra Anand
Aclaris Therapeutics | 4:持股变动声明-董事 SCHIFF ANDREW N
暂无数据